Versant Ventures
Liz is an Entrepreneur-in-Residence at Versant and Chief Business Officer at the firm's portfolio company, Seawolf Therapeutics.
Prior to becoming an EIR, Liz was SVP of Corporate Development at Versant’s Inception Therapeutics discovery engine, where she drove new company sourcing and played an integral role in operationalizing two Series A companies. Previously, Liz held various leadership roles driving corporate, science and IP strategy and business development at several emerging gene therapy companies including Avalanche Biotechnologies (now Adverum), 4D Molecular Therapeutics and CODA Biotherapeutics.
This person is not in any offices
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.